Health Care, Law & Legal, Lifestyle, Science

VANDA Pharmaceuticals recently announces FDA grants Orphan Drug Designation for VGT-1849B, a novel and selective candidate for the treatment of Polycythemia Vera

WASHINGTON — PRNewswire — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) on Aug. 28, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective peptide nucleic acid-based JAK2 inhibitor for the treatment of polycythemia vera (PV).

Business, Cultural Corner, Education, Politics

University of Virginia Darden School of Business, in collaboration with XED, launch the Darden CEO Leadership Program

MUMBAI, India — PRNewswire — The University of Virginia Darden School of Business, consistently ranked among the world’s top business schools, in collaboration with XED, recently announced the launch of the Darden CEO Leadership Program – a transformative initiative designed to equip senior leaders with